GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NexgenRx Inc (TSXV:NXG) » Definitions » Equity-to-Asset

NexgenRx (TSXV:NXG) Equity-to-Asset : 0.25 (As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is NexgenRx Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. NexgenRx's Total Stockholders Equity for the quarter that ended in Mar. 2025 was C$8.12 Mil. NexgenRx's Total Assets for the quarter that ended in Mar. 2025 was C$32.61 Mil. Therefore, NexgenRx's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.25.

The historical rank and industry rank for NexgenRx's Equity-to-Asset or its related term are showing as below:

TSXV:NXG' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.04   Med: 0.2   Max: 0.34
Current: 0.25

During the past 13 years, the highest Equity to Asset Ratio of NexgenRx was 0.34. The lowest was -0.04. And the median was 0.20.

TSXV:NXG's Equity-to-Asset is ranked worse than
78.99% of 690 companies
in the Healthcare Providers & Services industry
Industry Median: 0.49 vs TSXV:NXG: 0.25

NexgenRx Equity-to-Asset Historical Data

The historical data trend for NexgenRx's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NexgenRx Equity-to-Asset Chart

NexgenRx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.33 0.34 0.26 0.25

NexgenRx Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.26 0.26 0.25 0.25

Competitive Comparison of NexgenRx's Equity-to-Asset

For the Health Information Services subindustry, NexgenRx's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NexgenRx's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NexgenRx's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where NexgenRx's Equity-to-Asset falls into.


;
;

NexgenRx Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

NexgenRx's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=7.624/30.465
=0.25

NexgenRx's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=8.12/32.607
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NexgenRx  (TSXV:NXG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


NexgenRx Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of NexgenRx's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


NexgenRx Business Description

Traded in Other Exchanges
Address
191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6
NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. The various solutions offered by the company include; NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment, which is benefits administration services.
Executives
Paul Crossett 10% Security Holder
Kelly Tyler Ehler Senior Officer